NCT04595669

Personalised Advice for the Prevention of Metabolic Syndrome

Completed NA Last updated 23 October 2020

What this trial tests

NA trial testing Personalised advise in Metabolic Syndrome, Protection Against in 37 participants. Completed in 21 December 2017.

Timeline

4 September 2017

Primary endpoint
21 December 2017

21 December 2017

Quick facts

Lead sponsor	Wageningen University and Research
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	37
Start date	4 September 2017
Primary completion	21 December 2017
Estimated completion	21 December 2017
Sites	1 location across Netherlands

Drugs / interventions tested

• Personalised advise

Conditions studied

• Metabolic Syndrome, Protection Against — all drugs for Metabolic Syndrome, Protection Against →

Sponsor

Wageningen University and Research

Who can join

40 and older, any sex, with Metabolic Syndrome, Protection Against. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rationale: Improving dietary behaviours in view of optimising risk factors of metabolic syndrome requires behaviour change strategies. Tailored dietary advice, i.e. recommendations offered as a guide to action, can support behaviour change. In the current study we aim to learn how to better help consumers in their daily life to make lifestyle choices that better match their personal health target than their usual choices by providing personalised advice and feedback. In this study we target consumers at risk of metabolic syndrome (MetS) that are highly motivated to change their dietary behaviour in view of improving health.

Objective: The primary objective is to investigate the potential of personalised dietary advice and feedback for initiating and maintaining dietary changes by consumers at risk of MetS. In addition we want to evaluate understanding, applicability and personal benefit of personalised dietary advice and feedback by the target population to be able to further optimize the personalisation in future studies. The secondary objective is to explore potential effects of personalised dietary advice and feedback on subjective health and metabolic health parameters.

Study design: The study follows a one group pre-test post-test design with a duration of 16 weeks after the first advice is provided to the participants.

Study population: In total 40 adult men and women at risk of metabolic syndrome will be recruited from the consumer databases of Wageningen Food \& Biobased Research. Consumers are eligible for study participation when they are highly motivated to change dietary behaviour, willing to use technology, willing to share food purchase data as registered on a customer card of the supermarket, and in possession of a smart-phone.

Intervention: The intervention consists of personalised dietary advice and feedback on actual behaviour and health status that will be provided to study participants at set time points throughout the study period. The content of the advice will be generated partly automated based on dietary intake and parameters of metabolic health using knowledge rules that are developed for this study. During a consultation with the dietician, the advice is then translated in a dietary behaviour change strategy by taking into account individual preferences through motivational interviewing.

Main study parameters/endpoints: Primary outcomes of the study are the adequacy of intake of fruits, vegetables, whole grain products, dairy, fish, fats \& oils, red meat, processed meat, and sweetened beverages \& fruit juices as estimated by the online tool Eetscore. Furthermore consumer experiences and individual benefits of the provided personalised dietary advice are monitored on a weekly basis throughout the intervention period.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Exploring the Potential of Personalized Dietary Advice for Health Improvement in Motivated Individuals With Premetabolic Syndrome: Pretest-Posttest Study.
   van der Haar S, Hoevenaars FPM, van den Brink WJ, van den Broek T, et al · · 2021 · cited 10× · PMID 34185002 · DOI 10.2196/25043